Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
用户XI0e7myaIGWw
1个月前
40
10
已完结
1. 系统已在2025-10-17 14:09:52对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S0140-6736(25)01073-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673625010736
其他信息:
出版社: Elsevier BV
作者: Mazen Noureddin; Juan P Frias; Guy W Neff; K Jean Lucas; Cynthia Behling; Pierre Bedossa; Julie Dubourg; Doreen Chan; Mark Burch; Erica Fong; Brittany de Temple; Matt Minerva; Kim Barrett; Reshma Shringarpure; Erik J Tillman; Timothy Rolph; Andrew Cheng; Kitty Yale
